Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
SELECTA BIOSCIENCES INC
Jurisdiction of Incorporation/Organization
DELAWARE
Year of Incorporation/Organization
Over Five Years Ago
Item 2 Issuer Principal Place of Business and Contact Information
480 ARSENAL WAY
WATERTOWN, MA 02472
Phone Number:
subscription required
Item 3. Related Persons
Name
CARSTEN BRUNN
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
BRADFORD DAHMS
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
LLOYD JOHNSTON
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
TAKASHI KEI KISHIMOTO
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
ELONA KOGAN
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
ALISON SCHECTER
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
STEPHEN SMOLINSKI
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
TIMOTHY BARABE
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
CARRIE COX
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
SCOTT DUNSETH MYERS
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
AMIR NASHAT
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
AYMERIC SALLIN
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
TIMOTHY SPRINGER
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
PATRICK ZENNER
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
BIOTECHNOLOGY
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
12/18/2019
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
- Equity
- Option, Warrant or Other Right to Acquire Another Security
- Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 12. Sales Compensation
Recipient
CANTOR FITZGERALD LP
Recipient CRD Number
134
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
110 EAST 59TH STREET
4TH FLOOR
NEW YORK, NY 10022
States of Solicitation
Item 12. Sales Compensation
Recipient
NEEDHAM COMPANY
Recipient CRD Number
16360
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
250 PARK AVENUE
NEW YORK, NY 10177
States of Solicitation
Item 12. Sales Compensation
Recipient
CANACCORD GENUITY LLC
Recipient CRD Number
1020
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
535 MADISON AVENUE
NEW YORK, NY 10022
States of Solicitation
Item 12. Sales Compensation
Recipient
JANNEY MONTGOMERY SCOTT LLC
Recipient CRD Number
463
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
1717 ARCH STREET
PHILADELPHIA, PA 19103
States of Solicitation
Item 13. Offering and Sales Amounts
Total Offering Amount
70000000
Total Amount Sold
70000000
Total Remaining to be Sold
0
Clarification of Response
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
26
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
4200000.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Issuer Name
SELECTA BIOSCIENCES INC
Issuer Signature
/S/ MATTHEW W. BARTHOLOMAE
Signer Name
MATTHEW W. BARTHOLOMAE
Signer Title
ASSOCIATE GENERAL COUNSEL
Signature Date
01/02/2020